Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Corrigendum Open Access | 10.1172/jci.insight.187849

Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart

Joseph R. Visker, Ahmad A. Cluntun, Jesse N. Velasco-Silva, David R. Eberhardt, Luis Cedeño-Rosario, Thirupura S. Shankar, Rana Hamouche, Jing Ling, Hyoin Kwak, J. Yanni Hillas, Ian Aist, Eleni Tseliou, Sutip Navankasattusas, Dipayan Chaudhuri, Gregory S. Ducker, Stavros G. Drakos, and Jared Rutter

Find articles by Visker, J. in: PubMed | Google Scholar

Find articles by Cluntun, A. in: PubMed | Google Scholar |

Find articles by Velasco-Silva, J. in: PubMed | Google Scholar

Find articles by Eberhardt, D. in: PubMed | Google Scholar

Find articles by Cedeño-Rosario, L. in: PubMed | Google Scholar

Find articles by Shankar, T. in: PubMed | Google Scholar

Find articles by Hamouche, R. in: PubMed | Google Scholar

Find articles by Ling, J. in: PubMed | Google Scholar

Find articles by Kwak, H. in: PubMed | Google Scholar

Find articles by Hillas, J. in: PubMed | Google Scholar

Find articles by Aist, I. in: PubMed | Google Scholar

Find articles by Tseliou, E. in: PubMed | Google Scholar

Find articles by Navankasattusas, S. in: PubMed | Google Scholar

Find articles by Chaudhuri, D. in: PubMed | Google Scholar

Find articles by Ducker, G. in: PubMed | Google Scholar

Find articles by Drakos, S. in: PubMed | Google Scholar

Find articles by Rutter, J. in: PubMed | Google Scholar |

Published November 8, 2024 - More info

Published in Volume 9, Issue 21 on November 8, 2024
JCI Insight. 2024;9(21):e187849. https://doi.org/10.1172/jci.insight.187849.
© 2024 Visker et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 8, 2024 - Version history
View PDF

Related article:

Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart
Joseph R. Visker, Ahmad A. Cluntun, Jesse N. Velasco-Silva, David R. Eberhardt, Luis Cedeño-Rosario, Thirupura S. Shankar, Rana Hamouche, Jing Ling, Hyoin Kwak, J. Yanni Hillas, Ian Aist, Eleni Tseliou, Sutip Navankasattusas, Dipayan Chaudhuri, Gregory S. Ducker, Stavros G. Drakos, Jared Rutter
Joseph R. Visker, Ahmad A. Cluntun, Jesse N. Velasco-Silva, David R. Eberhardt, Luis Cedeño-Rosario, Thirupura S. Shankar, Rana Hamouche, Jing Ling, Hyoin Kwak, J. Yanni Hillas, Ian Aist, Eleni Tseliou, Sutip Navankasattusas, Dipayan Chaudhuri, Gregory S. Ducker, Stavros G. Drakos, Jared Rutter
We investigated a pharmacological approach to boost mitochondrial function and reduce the damage after a heart attack, which is a leading cause of death worldwide.
Research Article Cardiology Metabolism

Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart

  • Text
  • PDF
Abstract

The clinical therapy for treating acute myocardial infarction is primary percutaneous coronary intervention (PPCI). PPCI is effective at reperfusing the heart; however, the rapid reintroduction of blood can cause ischemia-reperfusion (I/R). Reperfusion injury is responsible for up to half of the total myocardial damage, but there are no pharmacological interventions to reduce I/R. We previously demonstrated that inhibiting monocarboxylate transporter 4 (MCT4) and redirecting pyruvate toward oxidation can blunt hypertrophy. We hypothesized that this pathway might be important during I/R. Here, we establish that the pyruvate-lactate axis plays a role in determining myocardial salvage following injury. After I/R, the mitochondrial pyruvate carrier (MPC), required for pyruvate oxidation, is upregulated in the surviving myocardium. In cardiomyocytes lacking the MPC, there was increased cell death and less salvage after I/R, which was associated with an upregulation of MCT4. To determine the importance of pyruvate oxidation, we inhibited MCT4 with a small-molecule drug (VB124) at reperfusion. This strategy normalized reactive oxygen species (ROS), mitochondrial membrane potential (ΔΨ), and Ca2+, increased pyruvate entry to the TCA cycle, increased oxygen consumption, and improved myocardial salvage and functional outcomes following I/R. Our data suggest normalizing pyruvate-lactate metabolism by inhibiting MCT4 is a promising therapy to mitigate I/R injury.

Authors

Joseph R. Visker, Ahmad A. Cluntun, Jesse N. Velasco-Silva, David R. Eberhardt, Luis Cedeño-Rosario, Thirupura S. Shankar, Rana Hamouche, Jing Ling, Hyoin Kwak, J. Yanni Hillas, Ian Aist, Eleni Tseliou, Sutip Navankasattusas, Dipayan Chaudhuri, Gregory S. Ducker, Stavros G. Drakos, Jared Rutter

×

Original citation JCI Insight. 2024;9(17):e180906. https://doi.org/10.1172/jci.insight.180906

Citation for this corrigendum: JCI Insight. 2024;9(21):e187849. https://doi.org/10.1172/jci.insight.187849

After publication, the authors became aware of labeling issues in the paper. d-glucose was inadvertently referred to as l-glucose in the Methods. In addition, the key for Figures 3, G–J, was incorrectly assigned green to the hypoxia group and red to the hypoxia+regeneration group. The correct version of these panels is shown below. These errors have been corrected in the PDF and HTML versions of the manuscript.

Figure 3

The authors regret the error.

Footnotes

See the related article at Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart.

Version history
  • Version 1 (November 8, 2024): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts